About Stabicon Life Sciences Private Limited
Data last updated:
Stabicon Life Sciences Private Limited is a private limited company based in Bengaluru, Karnataka, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 09 February 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2010PTC052428. Its GSTIN is 29AANCS8649D1ZQ (Karnataka). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹3.7 Cr. It is led by directors Palaniandy Krishnamurthy and Kushboo Ranka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at #4M – 413 Hrbr Layout 3rd Block Kamanahalli Main Road Kalyan Nagar, Bengaluru, Karnataka, India – 560043.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.34 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net profit of ₹29.13 Lakh (net margin 2.6%) and EBITDA of ₹2.66 Cr (EBITDA margin 23.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
The company has about 75 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Stabicon Life Sciences. As per MCA filings, the company has open charges of ₹10 Cr and satisfied charges of ₹3.6 Cr on record. The company has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.49 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (Contract Research) are compared by revenue, 5 larger and 5 smaller; the largest is Neocell Bio-Technologies Private Limited with revenue of ₹11.75 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 690 overdue payments to 109 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website stabicon.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address#4M – 413 Hrbr Layout 3rd Block Kamanahalli Main Road Kalyan Nagar, Bengaluru, Karnataka, India – 560043
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Stabicon Life Sciences Private Limited
The main business activity of Stabicon Life Sciences is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Stabicon Life Sciences Private Limited FY 2025 filings available
Stabicon Life Sciences Private Limited reported revenue of ₹11.34 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Stabicon Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 3% over three years, including 20% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Stabicon Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.66 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹29.13 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Stabicon Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Stabicon Life Sciences are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Stabicon Life Sciences Private Limited
Stabicon Life Sciences Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neocell Bio-Technologies Private Limited | ₹11.75 Cr (FY 2025) | •••• | •••• | 1184.0% | •••• | Patancheru, Telangana, India |
| Invengene Private Limited | ₹11.75 Cr (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Phastar Cro Private Limited | ₹11.72 Cr (FY 2025) | •••• | •••• | 69.0% | •••• | Bangalore, Karnataka, India |
| Fenix Research Labs Private Limited | ₹11.62 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Hyderabad, Telangana, India |
| Creyon Bio India Private Limited | ₹11.5 Cr (FY 2025) | •••• | •••• | 26.0% | •••• | Bangalore, Karnataka, India |
| Stabicon Life Sciences Private Limited this company | ₹11.34 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Bengaluru, Karnataka, India |
| Etico Lifesciences Private Limited | ₹11.15 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Cisen Pharmaceuticals India Private Limited | ₹11.03 Cr (FY 2025) | •••• | •••• | -22.0% | •••• | Salcette, Goa, India |
| Callidus Research Laboratories Private Limited | ₹10.99 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Pune, Maharashtra, India |
| Atorus Research India Private Limited | ₹10.87 Cr (FY 2024) | •••• | •••• | 93.0% | •••• | Bangalore, Karnataka, India |
| Avigya Biosciences Private Limited | ₹10.85 Cr (FY 2024) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Stabicon Life Sciences by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Stabicon Life Sciences Private Limited
Stabicon Life Sciences Private Limited is audited by B S D & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| B S D & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Stabicon Life Sciences Private Limited
Stabicon Life Sciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palaniandy Krishnamurthy | Director | 04 May 2021 | 5 Years 5 Months | Current |
| Kushboo Ranka Also directs: H K Technologies LLP, Veristonn Sciences Private Limited | Director | 12 Feb 2010 | 16 Years 7 Months | Current |
Ownership and Shareholding of Stabicon Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Stabicon Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Oct 2025 | Others | ₹10 Cr | Open |
| 26 Sep 2020 | Others | ₹27.88 Lakh | Satisfied |
| 28 Feb 2011 | State Bank of India | ₹3.32 Cr | Satisfied |
Total charge records: 3 View all charges
Deals & Funding of Stabicon Life Sciences Private Limited
Stabicon Life Sciences Private Limited has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.49 Cr; the latest was in March 2021.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: H K Technologies Limited , an individual Seller: Dossier Solutions and Services Private Limited , Suresh Khanna Huf, 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: Dossier Solutions and Services Private Limited , an individual |
| May 2017 | Rights issue | ₹1.2 Cr | Investors: H K Technologies Limited , Tuscan Consultants and Developers Private Limited , Dossier Solutions and Services Private Limited |
| May 2013 | Funding round | ₹1.5 Cr | Investors: H K Technologies Limited , Tuscan Consultants and Developers Private Limited , Dossier Solutions and Services Private Limited |
| Nov 2011 | Secondary share transfer | Undisclosed | Buyer: H K Technologies Limited , Dossier Solutions and Services Private Limited , 2 individuals Seller: an individual |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by Stabicon Life Sciences Private Limited
Stabicon Life Sciences Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 690 overdue payments to 109 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 109)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Lab Chem Solutions | •••• | •••• | •••• |
| Swen Hvac Engineers Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 14 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Stabicon Life Sciences Private Limited
Stabicon Life Sciences operates one associated brand: Stabicon Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers stability testing, formulation, and analytical services for pharmaceuticals and FMCG sectors. | stabicon.com |
Employees and EPFO Compliance at Stabicon Life Sciences Private Limited
Stabicon Life Sciences Private Limited has a workforce of 75 employees as of Apr 08, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Stabicon Life Sciences Private Limited
Stabicon Life Sciences Private Limited has 7 board changes on record since 2010: 2 appointments and 5 cessations. The latest: Medipalli Sreehari ceased to be Director on 31 Dec 2021.
4 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Stabicon Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Stabicon Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Stabicon Life Sciences Private Limited
Stabicon Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AANCS8649D1ZQ | Karnataka | Active | 01 Jul 2017 |
| 34AANCS8649D1ZZ | Puducherry | Active | 12 Jan 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Stabicon Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Stabicon Life Sciences Private Limited
Stabicon Life Sciences is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 09 February 2010 (16+ years old) and is registered under CIN U73100KA2010PTC052428.
Stabicon Life Sciences reported revenue of ₹11.34 Cr for FY 2025 (up 20% YoY).
Stabicon Life Sciences has 2 current directors:
- Palaniandy Krishnamurthy - Director
- Kushboo Ranka - Director
Stabicon Life Sciences reported a net profit of ₹29.13 Lakh (net margin 2.6%) and EBITDA of ₹2.66 Cr (EBITDA margin 23.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Stabicon Life Sciences is 3% over three years. In the latest year (FY 2025) revenue rose 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Stabicon Life Sciences is 29AANCS8649D1ZQ, registered in Karnataka. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 34AANCS8649D1ZZ (Puducherry).
The CIN (Corporate Identification Number) of Stabicon Life Sciences is U73100KA2010PTC052428. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stabicon Life Sciences was incorporated on 09 February 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Stabicon Life Sciences has 7 deals on record (4 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹2.49 Cr; the latest was in March 2021.
The peers of Stabicon Life Sciences by revenue are Neocell Bio-Technologies Private Limited, Invengene Private Limited, Phastar Cro Private Limited, Fenix Research Labs Private Limited, Creyon Bio India Private Limited and 5 more, all in the Pharma industry (Contract Research).
Medipalli Sreehari ceased to be Director on 31 Dec 2021. Palaniandy Krishnamurthy ceased to be Additional Director on 30 Nov 2021. Palaniandy Krishnamurthy was appointed as Director on 04 May 2021. Stabicon Life Sciences has 7 board changes on record in total.
Yes, Stabicon Life Sciences is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).